Patent AnalyticsExaminers
Rankings

Company or institution

IDERA PHARMACEUTICALS, INC.

59 applicationsfiled 2006 to 2021

Allowance rate
42%
−33 pts vs the USPTO range 31% to 55%
Rejections before allowance
1.5
level with the USPTO
Months to first action
15.0 mo
−3.6 vs the USPTO
Needed an RCE
14%
−14 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C12N Microorganisms or enzymes32 apps
A61K Medical preparations24 apps
C07H 3 apps

Art units

163517 apps
164514 apps
16749 apps
16334 apps
16363 apps
16423 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
17543341IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT2021-12-06Abandoned00n/a
17286209TLR9 MODULATORS FOR TREATING CANCER2021-04-16Abandoned0034.2 mo
17226866USE OF A TLR9 AGONIST IN METHODS FOR TREATING COVID-192021-04-09Abandoned1022.9 mo
15514389Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15508899Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15255663Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15228613Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15230857Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15632664Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15909972Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 59 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in